Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma.
about
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinomaLiver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewSelection of patients with hepatocellular carcinoma for liver transplantation: Past and futurePrediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationOutcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting listValidating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database.Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 MonthsAlpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.Deceased-donor split-liver transplantation in adult recipients: is the learning curve over?Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.Update on biomarkers of hepatocellular carcinoma.Waitlist priority for hepatocellular carcinoma beyond milan criteria: a potentially appropriate decision without a structured approach.Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation.Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?Can response to locoregional therapy help predict long-term survival after liver transplantation for hepatocellular carcinoma? A systematic review.Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma.Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria.Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach.Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.The 4th Asia-Pacific Primary Liver Cancer Expert MeetingPredictive models for recurrence risk of hepatocellular carcinoma after liver transplantation: Still an unmet need.Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma.Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.Screening for hepatocellular carcinoma: What is missing?Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels.
P2860
Q26740332-A28769BD-C655-49CA-98AC-B6796D685AFBQ26750463-8AB4E00C-2E54-4A85-9A00-23CD3CFC5C11Q26771246-238613A0-7CAC-419C-A49B-4CAAEC9566D2Q26772329-3207A68F-C6F9-4548-9608-A3029939DF0EQ28649715-52C16A0D-D9DC-48BA-BEAD-7FC66C831AE6Q34987874-9BBB1DD2-ADA1-4A92-8DD6-702B6D92D86BQ36478238-EA64006E-D04F-49FC-A039-D8047A082928Q36728731-DCDB1D44-E6B6-4CBA-8EEF-2FEF7187332CQ36926615-54ED6928-95FF-46A1-B229-3C4199AF1CE0Q36962089-76DB3175-A161-44E2-93E4-AD96696F5D25Q37348887-49B1835C-CF3B-491C-A60A-428D7F9A75E5Q37747422-17CDFC06-DADD-438B-8CA1-5E8B57C1ED31Q38166133-0232B81B-8176-4F79-B767-289F681C97BEQ38168622-7566BD5D-1891-49C5-A505-178EFE3B4194Q38269467-E99D80BB-0C27-4071-8C38-046A4399A872Q38795885-049020F8-6634-440D-8243-3617E145CC42Q38976824-E678D315-DF80-4775-A6D2-8EB450CC38D8Q39049991-CF0F5A9C-4BFB-440A-848B-DFCBFCCCEFBFQ39067623-3FC6A114-799E-492B-A7CF-316B4705908DQ39149264-4FD92E70-B441-4BA8-8956-48788476CC73Q41669686-41DDFA64-3DC4-4EB8-9C75-D936CA94B5DDQ42256347-BA33E58E-569F-411F-A087-5E1F3FFC2667Q42349921-438B7E59-5BD3-43D4-95A3-F6BB7E231D29Q42695215-E4A8C338-A287-43FD-B231-89ED8EF05568Q43916781-09E09C22-57A0-4ACC-848B-81985DF02923Q47121517-515DBC6C-C288-4AEB-A5C0-207B15853A8CQ48217612-E57B989E-4A46-4868-BFAF-32BC91247755Q50099732-724BF282-8AFB-4A73-A928-BDAA8066CBBAQ50244078-7F52367E-2C6C-43B3-B0C8-5F1E9E7D1FD2Q54468930-31E33D38-7526-4187-9B1E-D4BA5767C76AQ55293155-048206BE-1696-47ED-8173-7702054E5EEF
P2860
Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Serum alpha-fetoprotein level ...... with hepatocellular carcinoma.
@en
Serum alpha-fetoprotein level ...... with hepatocellular carcinoma.
@nl
type
label
Serum alpha-fetoprotein level ...... with hepatocellular carcinoma.
@en
Serum alpha-fetoprotein level ...... with hepatocellular carcinoma.
@nl
prefLabel
Serum alpha-fetoprotein level ...... with hepatocellular carcinoma.
@en
Serum alpha-fetoprotein level ...... with hepatocellular carcinoma.
@nl
P2860
P356
P1476
Serum alpha-fetoprotein level ...... with hepatocellular carcinoma.
@en
P2093
George N Ioannou
Kristin Berry
P2860
P304
P356
10.1002/LT.23652
P577
2013-06-01T00:00:00Z